Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
268280.KS Stock Summary
Top 10 Correlated ETFs
268280.KS
In the News
268280.KS Financial details
Company Rating
Strong Buy
Market Cap
703.51B
Income
18.6B
Revenue
437.67B
Book val./share
75776.5
Cash/share
20234.63
Dividend
700
Dividend %
0.52%
Employees
456
Optionable
No
Shortable
Yes
Earnings
31 Mar 2023
P/E
50.24
Forward P/E
-
PEG
-7.09
P/S
1.39
P/B
1.78
P/C
6.98
P/FCF
11.54
Quick Ratio
-
Current Ratio
3.9
Debt / Equity
0.09
LT Debt / Equity
-
-
-
EPS (TTM)
3.77K
EPS next Y
-
EPS next Q
-
EPS this Y
-70.94%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-13.04%
Revenue last 5Y
2.98%
Revenue Q/Q
-9.81%
EPS Q/Q
-35.6%
-
-
-
-
SMA20
7.53%
SMA50
7.43%
SMA100
2.17%
Inst Own
-
Inst Trans
-
ROA
3%
ROE
4%
ROC
0.04%
Gross Margin
13%
Oper. Margin
3%
Profit Margin
3%
Payout
34%
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
128000.0-161800.0
52W High
-12.73%
52W Low
+10.31%
RSI
62
Rel Volume
1.19
Avg Volume
973
Volume
1.16K
Perf Week
-1.19%
Perf Month
5.53%
Perf Quarter
2.77%
Perf Half Y
4.28%
-
-
-
-
Beta
-0.02
-
-
Volatility
783.76%, 4464.13%
Prev Close
-0.14%
Price
141200
Change
-0.91%
268280.KS Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2023-12-31
Metric | History | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 72.19K | 72.64K | 105.71K | 122.02K | 88.41K | |
Net income per share | 7.56K | 6.77K | 15.9K | 12.93K | 3.76K | |
Operating cash flow per share | 13.16K | 13.74K | 6.46K | 7.87K | 22.12K | |
Free cash flow per share | 9.45K | 9.73K | -2.62K | -2.23K | 17K | |
Cash per share | 10.97K | 14.65K | 11.62K | 7.97K | 20.12K | |
Book value per share | 47.63K | 50.98K | 64.96K | 75.58K | 75.36K | |
Tangible book value per share | 47.21K | 50.61K | 64.63K | 75.29K | 75.08K | |
Share holders equity per share | 47.63K | 50.98K | 64.96K | 75.58K | 75.36K | |
Interest debt per share | 3.21K | 2.61K | 5.32K | 7.77K | 7.07K | |
Market cap | 377.9B | 535.17B | 1098.23B | 771.94B | 670.78B | |
Enterprise value | 341.55B | 468.42B | 1064.36B | 767.68B | 604.21B | |
P/E ratio | 9.55 | 15.44 | 13.74 | 11.91 | 36.05 | |
Price to sales ratio | 1 | 1.44 | 2.07 | 1.26 | 1.53 | |
POCF ratio | 5.49 | 7.6 | 33.85 | 19.58 | 6.12 | |
PFCF ratio | 7.64 | 10.74 | -83.43 | -69.2 | 7.97 | |
P/B Ratio | 1.52 | 2.05 | 3.36 | 2.04 | 1.8 | |
PTB ratio | 1.52 | 2.05 | 3.36 | 2.04 | 1.8 | |
EV to sales | 0.9 | 1.26 | 2 | 1.26 | 1.38 | |
Enterprise value over EBITDA | 5.18 | 7.45 | 8.7 | 7.23 | 11.91 | |
EV to operating cash flow | 4.96 | 6.66 | 32.81 | 19.47 | 5.52 | |
EV to free cash flow | 6.91 | 9.4 | -80.85 | -68.82 | 7.18 | |
Earnings yield | 0.1 | 0.06 | 0.07 | 0.08 | 0.03 | |
Free cash flow yield | 0.13 | 0.09 | -0.01 | -0.01 | 0.13 | |
Debt to equity | 0.07 | 0.05 | 0.08 | 0.1 | 0.09 | |
Debt to assets | 0.05 | 0.04 | 0.06 | 0.08 | 0.07 | |
Net debt to EBITDA | -0.55 | -1.06 | -0.28 | -0.04 | -1.31 | |
Current ratio | 5.06 | 4.94 | 3.02 | 3.59 | 4.01 | |
Interest coverage | 210.25 | 273.45 | 1.56K | 70.82 | 9.88 | |
Income quality | 1.74 | 2.03 | 0.41 | 0.61 | 5.89 | |
Dividend Yield | 0.02 | 0.02 | 0.01 | 0.01 | 0.02 | |
Payout ratio | 0.22 | 0.26 | 0.12 | 0.18 | 0.56 | |
Sales general and administrative to revenue | 0 | 0 | 0 | 0 | 0 | |
Research and developement to revenue | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | |
Intangibles to total assets | 0.01 | 0.01 | 0 | 0 | 0 | |
Capex to operating cash flow | -0.28 | -0.29 | -1.41 | -1.28 | -0.23 | |
Capex to revenue | -0.05 | -0.06 | -0.09 | -0.08 | -0.06 | |
Capex to depreciation | -1.23 | -1.25 | -2.72 | -2.49 | -0.88 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 90.01K | 88.12K | 152.44K | 148.3K | 79.83K | |
ROIC | 0.14 | 0.14 | 0.2 | 0.15 | 0.04 | |
Return on tangible assets | 0.13 | 0.11 | 0.18 | 0.14 | 0.04 | |
Graham Net | 16.6K | 18.68K | 17.7K | 20.57K | 25.22K | |
Working capital | 163.94B | 173.4B | 195.51B | 214.97B | 214.11B | |
Tangible asset value | 247.1B | 259.17B | 324.83B | 377.39B | 371.66B | |
Net current asset value | 141.8B | 151.41B | 180.92B | 200.97B | 197.01B | |
Invested capital | 0.07 | 0.05 | 0.08 | 0.1 | 0.09 | |
Average receivables | 79.4B | 74.01B | 91.12B | 118.88B | 107.34B | |
Average payables | 17.43B | 20.07B | 25.68B | 25.02B | 18.64B | |
Average inventory | 71.29B | 67.67B | 92.16B | 123.9B | 112.38B | |
Days sales outstanding | 72.4 | 71.69 | 74.99 | 76.74 | 71.79 | |
Days payables outstanding | 22.67 | 26.08 | 27.87 | 15.1 | 16.5 | |
Days of inventory on hand | 85.52 | 78.55 | 111.31 | 96.77 | 92.35 | |
Receivables turnover | 5.04 | 5.09 | 4.87 | 4.76 | 5.08 | |
Payables turnover | 16.1 | 13.99 | 13.1 | 24.17 | 22.13 | |
Inventory turnover | 4.27 | 4.65 | 3.28 | 3.77 | 3.95 | |
ROE | 0.16 | 0.13 | 0.24 | 0.17 | 0.05 | |
Capex per share | -3.71K | -4.01K | -9.07K | -10.09K | -5.12K |
Quarterly Fundamentals Overview
Last date of statement is 2023-12-31 for Q4
Metric | History | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 27.34K | 22.18K | 22.65K | 23.23K | 20.61K | |
Net income per share | -309.21 | 1.3K | 512.64 | 1.19K | 766.94 | |
Operating cash flow per share | 4.66K | 4.59K | 5.9K | 5.48K | 6.22K | |
Free cash flow per share | 2.72K | 3.71K | 5.73K | 1.74K | 5.82K | |
Cash per share | 7.98K | 11.84K | 14.76K | 15.56K | 20.23K | |
Book value per share | 75.68K | 75.25K | 75.47K | 77.21K | 75.78K | |
Tangible book value per share | 75.39K | 74.96K | 75.19K | 76.92K | 75.49K | |
Share holders equity per share | 75.68K | 75.25K | 75.47K | 77.21K | 75.78K | |
Interest debt per share | 7.65K | 6.56K | 7.92K | 8.32K | 6.78K | |
Market cap | 770.92B | 689.15B | 775.69B | 691.6B | 667.08B | |
Enterprise value | 766.67B | 681.78B | 737.94B | 653.11B | 600.52B | |
P/E ratio | -124.51 | 26.47 | 75.98 | 29.98 | 44.17 | |
Price to sales ratio | 5.63 | 6.21 | 6.88 | 6.15 | 6.57 | |
POCF ratio | 33.02 | 30.01 | 26.39 | 26.05 | 21.79 | |
PFCF ratio | 56.69 | 37.15 | 27.18 | 81.97 | 23.29 | |
P/B Ratio | 2.03 | 1.83 | 2.06 | 1.85 | 1.79 | |
PTB ratio | 2.03 | 1.83 | 2.06 | 1.85 | 1.79 | |
EV to sales | 5.6 | 6.15 | 6.54 | 5.8 | 5.92 | |
Enterprise value over EBITDA | 225.25 | 58.28 | 52.38 | 47.77 | 44.5 | |
EV to operating cash flow | 32.84 | 29.69 | 25.1 | 24.6 | 19.62 | |
EV to free cash flow | 56.38 | 36.76 | 25.85 | 77.4 | 20.96 | |
Earnings yield | 0 | 0.01 | 0 | 0.01 | 0.01 | |
Free cash flow yield | 0.02 | 0.03 | 0.04 | 0.01 | 0.04 | |
Debt to equity | 0.1 | 0.1 | 0.1 | 0.11 | 0.09 | |
Debt to assets | 0.08 | 0.08 | 0.08 | 0.09 | 0.07 | |
Net debt to EBITDA | -1.25 | -0.63 | -2.68 | -2.82 | -4.93 | |
Current ratio | 3.59 | 3.62 | 4.28 | 3.9 | 4.01 | |
Interest coverage | -3.67 | -0.75 | 11.99 | 9.66 | 10.22 | |
Income quality | -15.08 | 3.53 | 11.52 | 4.6 | 8.11 | |
Dividend Yield | 0 | 0 | 0.01 | 0.01 | 0 | |
Payout ratio | 0 | 0 | 2.75 | 0.6 | 0 | |
Sales general and administrative to revenue | 0 | 0.07 | 0.07 | 0.07 | 0 | |
Research and developement to revenue | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | |
Intangibles to total assets | 0 | 0 | 0 | 0 | 0 | |
Capex to operating cash flow | -0.42 | -0.19 | -0.03 | -0.68 | -0.06 | |
Capex to revenue | -0.07 | -0.04 | -0.01 | -0.16 | -0.02 | |
Capex to depreciation | -1.83 | -0.67 | -0.12 | -2.51 | -0.27 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 22.95K | 46.94K | 29.51K | 45.48K | 36.16K | |
ROIC | 0 | 0.01 | 0.01 | 0.01 | 0.01 | |
Return on tangible assets | 0 | 0.01 | 0.01 | 0.01 | 0.01 | |
Graham Net | 20.6K | 22.42K | 24.61K | 24.12K | 25.36K | |
Working capital | 214.97B | 214.94B | 220.2B | 207.65B | 214.11B | |
Tangible asset value | 377.39B | 374.9B | 374.37B | 372.54B | 371.66B | |
Net current asset value | 200.97B | 200.54B | 204.17B | 191.34B | 197.01B | |
Invested capital | 0.1 | 0.1 | 0.1 | 0.11 | 0.09 | |
Average receivables | -18.3B | 126.2B | 117.15B | 112.99B | 100.78B | |
Average payables | 21.6B | 19.57B | 16.88B | 15.77B | 17.25B | |
Average inventory | 134.27B | 120.22B | 105.96B | 92.14B | 91.58B | |
Days sales outstanding | 84.56 | 100.47 | 88.19 | 92.36 | 76.34 | |
Days payables outstanding | 15.45 | 17.49 | 13.2 | 15.54 | 17.98 | |
Days of inventory on hand | 99.02 | 102.73 | 90.01 | 77.93 | 100.68 | |
Receivables turnover | 1.06 | 0.9 | 1.02 | 0.97 | 1.18 | |
Payables turnover | 5.82 | 5.15 | 6.82 | 5.79 | 5 | |
Inventory turnover | 0.91 | 0.88 | 1 | 1.15 | 0.89 | |
ROE | 0 | 0.02 | 0.01 | 0.02 | 0.01 | |
Capex per share | -1.95K | -883.41 | -171.31 | -3.74K | -399.71 |
268280.KS Frequently Asked Questions
What is Miwon Specialty Chemical Co., Ltd. stock symbol ?
Miwon Specialty Chemical Co., Ltd. is a KR stock and trading under the symbol 268280.KS
What is Miwon Specialty Chemical Co., Ltd. stock quote today ?
Miwon Specialty Chemical Co., Ltd. stock price is $141200 today.
Is Miwon Specialty Chemical Co., Ltd. stock public?
Yes, Miwon Specialty Chemical Co., Ltd. is a publicly traded company.